U.S. Neurology Devices Market to Reach USD 11.57B by 2035

Market Outlook

By 2035, the U.S. Neurology Devices Market is expected to reach approximately USD 11.57 billion, expanding at a CAGR of 8.93% during the forecast period 2026–2035. The market is estimated at USD 4.92 billion in 2025, 3.84 billion in 2022, USD 4.17 billion in 2023, and USD 4.52 billion in 2024. The first forecast year, 2026, is expected to approach USD 5.36 billion. Values in this report are expressed in USD billions.

The U.S. neurology devices industry occupies a strategically important position within the medical device ecosystem because neurological care combines high disease burden, specialist-intensive treatment, sophisticated capital equipment, implantable therapies, emergency intervention, recurring diagnostic monitoring, and complex long-term disease management. Stroke, epilepsy, Parkinson’s disease, essential tremor, hydrocephalus, traumatic brain injury, neurovascular abnormalities, brain tumors, movement disorders, chronic neurological pain, and other neurological conditions collectively create a substantial device-dependent care pathway.

The clinical burden is significant. More than 795,000 people experience a stroke in the United States every year, with a stroke occurring approximately every 40 seconds. About 87% of strokes are ischemic, directly supporting the need for neurovascular imaging, aspiration catheters, stent retrievers, guide catheters, microcatheters, embolization systems, flow diverters, access devices, and other neurointerventional technologies. Approximately 3 million U.S. adults are estimated to have active epilepsy, while hundreds of thousands of children also live with active epilepsy. Parkinson’s disease affects more than 1.1 million people nationally, with approximately 90,000 new diagnoses annually. Alzheimer’s disease and other neurodegenerative disorders further increase the demand for advanced neurological assessment, imaging, monitoring, and emerging technology platforms.

The U.S. neurological device market is therefore evolving beyond traditional neurosurgical instruments and conventional electrical stimulation. Growth is increasingly concentrated around adaptive deep brain stimulation, responsive neurostimulation, mechanical thrombectomy, flow diversion, advanced aspiration systems, minimally invasive intracranial access, MR-guided focused ultrasound, AI-supported EEG analysis, stereotactic navigation, robotic neurosurgery, intracranial pressure monitoring, digital neurophysiology, and data-driven chronic neurological management.

Hospital procurement behavior is also changing. Large health systems are evaluating neurological technologies through the economics of the complete care episode rather than device acquisition price alone. Technologies capable of accelerating door-to-reperfusion time in stroke, reducing operating room utilization, shortening intensive-care exposure, improving seizure management, reducing repeat hospitalization, expanding outpatient treatment, or allowing clinicians to manage larger patient populations can justify premium pricing despite increasing capital-budget scrutiny.

The market model used for this report covers neurology-specific therapeutic, interventional, surgical, stimulation, cerebrospinal fluid management, and diagnostic or monitoring devices. Pharmaceutical treatments and general hospital services are excluded. General-purpose MRI and CT systems are not counted as full neurology-device revenue unless incorporated into a dedicated neurological procedural platform, avoiding artificial inflation of the addressable market.

The historical expansion from approximately USD 3.55 billion in 2021 to USD 4.52 billion in 2024 was supported by recovery in elective neurological procedures, higher mechanical thrombectomy volumes, renewed capital investment in neurological operating rooms and neurodiagnostic laboratories, greater utilization of neuromodulation, and growing adoption of minimally invasive neurovascular technologies. The market reached approximately USD 4.92 billion in 2025 as neurovascular intervention, adaptive neuromodulation, advanced EEG systems, image-guided neurosurgery, and focused ultrasound entered a stronger investment cycle.

Introduction

According to the U.S. Neurology Devices Market Report, neurological care represents one of the most technology-intensive areas of American medicine. Diagnosis and treatment frequently require coordinated use of neuroimaging, physiological monitoring, endovascular intervention, stereotactic navigation, implantable stimulation, microsurgical instruments, cerebrospinal fluid diversion, neurocritical-care monitoring, and long-term digital follow-up.

The underlying patient pool is both large and clinically diverse. Stroke creates immediate demand for emergency neurointervention. Epilepsy generates recurring demand for EEG, long-term monitoring, responsive neurostimulation, vagus nerve stimulation, and surgical evaluation. Parkinson’s disease and essential tremor support deep brain stimulation and focused ultrasound programs. Hydrocephalus requires shunts, valves, drainage systems, and intracranial pressure management. Traumatic brain injury creates demand for neurocritical-care monitoring, pressure management, cranial surgery, and rehabilitation technologies.

The economic burden surrounding these conditions is equally important. Parkinson’s disease alone is associated with tens of billions of dollars in direct and indirect U.S. costs. Epilepsy-related healthcare spending is measured in the tens of billions. Dementia-related health and long-term care costs now run into hundreds of billions annually. These disease costs do not translate directly into device revenue, but they demonstrate why health systems and payers remain interested in technologies that can reduce acute events, preserve neurological function, shorten hospitalization, or delay higher-cost care.

The U.S. hospital infrastructure provides a substantial commercial base. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and more than 35 million annual hospital admissions. Neurology device procurement, however, is disproportionately concentrated in academic medical centers, comprehensive stroke centers, Level I trauma centers, epilepsy centers, neuroscience institutes, major integrated delivery networks, and high-volume tertiary referral hospitals.

Large health systems increasingly prefer neurological technology platforms instead of isolated devices. A neurovascular vendor that combines access, aspiration, thrombectomy, embolization, and physician education can command a stronger strategic position than a single-product supplier. Similarly, neuromodulation companies increasingly compete through sensing capabilities, programming software, implantable generators, leads, remote support, and longitudinal data rather than the implant alone.

Between 2026 and 2035, neurological device competition will move toward systems that can diagnose earlier, intervene more precisely, personalize therapy and generate continuous objective evidence. The commercial advantage will increasingly belong to technologies capable of improving both clinical outcomes and neurological service-line productivity.

Key Market Drivers: What’s Fueling the U.S. Neurology Devices Market Boom?

The first and most fundamental growth driver is the scale of neurological disease in the United States. More than 795,000 strokes occur each year, including approximately 610,000 first or new strokes. Stroke alone creates one of the strongest procedure-driven neurology device markets because treatment outcomes are extremely time-sensitive. Comprehensive stroke centers are consequently investing in advanced thrombectomy systems, aspiration technology, neuroangiography infrastructure, flow-control systems, embolization platforms, and increasingly efficient catheter-delivery systems.

Epilepsy is another major demand generator. Approximately 3 million U.S. adults live with active epilepsy, in addition to a substantial pediatric population. Although pharmacological therapy remains first-line treatment, a clinically meaningful subset remains inadequately controlled. This sustains demand for inpatient and ambulatory EEG, long-term video EEG, intracranial monitoring, stereoelectroencephalography, vagus nerve stimulation, responsive neurostimulation, deep brain stimulation, and neurosurgical planning technologies.

Movement disorders provide a third important growth engine. More than 1.1 million people are estimated to live with Parkinson’s disease in the U.S., and approximately 90,000 people are diagnosed annually. The commercial opportunity is expanding because advanced therapy is no longer limited to conventional open neurosurgery. Adaptive deep brain stimulation, directional leads, rechargeable implantable pulse generators, sensing-enabled stimulation and MR-guided focused ultrasound are broadening the range of technology available to neurologists and functional neurosurgeons.

A fourth driver is the continued transition toward minimally invasive neurological intervention. Mechanical thrombectomy changed acute ischemic stroke treatment by allowing endovascular clot removal in appropriately selected patients. Flow diverters, intrasaccular devices, next-generation coils, liquid embolics, aspiration catheters, microcatheters, and sophisticated access platforms are similarly reducing reliance on open cerebrovascular surgery for selected aneurysms and vascular malformations.

Hospital procurement economics represent another major driver. Neuroscience programs can be expensive to build because they require neurointerventional suites, advanced imaging, operating-room infrastructure, neurocritical-care beds, trained nurses, neurologists, neurosurgeons, interventional neuroradiologists, electrophysiology technologists, and specialized service support. Once this infrastructure exists, however, hospitals have a strong incentive to increase procedure throughput and referral capture. Devices that shorten cases, reduce complications, improve scheduling reliability or increase utilization of existing capital assets can gain purchasing priority.

A sixth driver is the growth of neurodiagnostic monitoring outside the traditional inpatient laboratory. Portable EEG, ambulatory EEG, home seizure monitoring, wearable neurological sensing, cloud-connected neurophysiology, and AI-supported signal interpretation are increasingly useful in a healthcare environment constrained by specialist availability. Technologies capable of reducing manual review time can materially improve the economics of neurology practices and epilepsy centers.

Demographic aging reinforces virtually every major segment. Parkinson’s disease, dementia, stroke, hydrocephalus in older populations, and several movement disorders become increasingly important as the U.S. population ages. This creates not only higher procedural demand but also greater pressure to develop treatment models that reduce inpatient care and caregiver burden.

Finally, the United States remains a globally important neurological device innovation market because of its FDA regulatory system, reimbursement scale, academic research infrastructure, clinical-trial networks, specialist concentration, venture-capital ecosystem, and high procedural values. Manufacturers able to produce strong clinical evidence and a convincing health-economic argument can achieve rapid adoption within influential neuroscience centers.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Adaptive deep brain stimulation represents one of the most significant shifts in functional neurosurgery. Conventional DBS delivers stimulation according to programmed parameters. New sensing-enabled systems can detect relevant neurological signals and adjust stimulation according to patient-specific brain activity. This moves the market toward closed-loop neuromodulation rather than continuously delivered fixed stimulation.

For hospitals, adaptive DBS is commercially important because it creates differentiation for movement-disorder programs while potentially improving therapy personalization. For device manufacturers, it expands competition beyond battery longevity and electrode design toward algorithms, neural sensing, programming software, data interpretation, and platform integration.

Responsive neurostimulation is developing along a similar trajectory in epilepsy. Long-term intracranial electrophysiological data can be used to identify seizure patterns and deliver targeted stimulation. The addition of artificial intelligence to electrophysiological review is particularly important because neurological data volumes are increasing faster than specialist capacity. AI-assisted interpretation may therefore create value through workflow efficiency as much as through clinical sophistication.

Neurovascular innovation is focused heavily on first-pass reperfusion, large-bore aspiration, distal access, vessel navigability and treatment of difficult clot morphology. In acute stroke, the economic objective is straightforward: restore cerebral blood flow rapidly while minimizing procedural complications. Device companies are refining catheter trackability, aspiration force, stent-retriever design, access support, and workflow integration to improve reperfusion performance.

Aneurysm treatment is another highly innovative area. Flow-diversion technology, embolic coils, intrasaccular implants, braided stents, liquid embolics, balloons, and advanced microcatheters allow treatment of aneurysms that historically required more invasive surgery or were considered difficult to treat. Continued innovation in device sizing, deliverability and vessel-wall reconstruction should support premium neurovascular growth.

MR-guided focused ultrasound is expanding the strategic boundaries of neurological devices. The approach allows physicians to create highly localized intracranial lesions without conventional cranial incisions or permanent implanted stimulation hardware. It has gained importance in essential tremor and Parkinson’s disease treatment and is increasingly relevant for neuroscience programs seeking differentiated minimally invasive treatment capability.

Image-guided and robotic neurosurgery are also advancing. Stereotactic navigation, robotic trajectory planning, intraoperative imaging, augmented visualization and software-based surgical planning improve accuracy for electrode implantation, biopsy, tumor surgery and epilepsy procedures. These technologies are attractive to high-volume centers because they can standardize complex workflows and potentially reduce variability between operators.

Neurocritical-care technology is becoming more integrated. Intracranial pressure monitors, external ventricular drainage systems, multimodal monitoring platforms, cerebral oxygenation tools and advanced analytics are increasingly evaluated as part of an interconnected neuro-ICU environment rather than separate products.

Manufacturers are simultaneously emphasizing implant longevity and patient convenience. Rechargeable neurostimulators, smaller implantable pulse generators, MRI compatibility, remote programming and simplified patient controllers can reduce replacement burden and improve the usability of chronic implanted therapy.

The larger innovation trend is therefore convergence. Neurological devices are becoming combinations of hardware, sensing, software, imaging, data and therapy. By 2035, the most defensible competitive positions are likely to belong to companies that own multiple parts of that clinical pathway.

Segmentation Insights

The U.S. Neurology Devices Market is segmented on the basis of product category, application, technology type, and end user.

By Product Category

Neurostimulation and Neuromodulation Devices

Neurostimulation represents the largest high-value product category. The segment includes deep brain stimulators, spinal cord stimulators used within neurological and pain-management pathways, vagus nerve stimulators, responsive neurostimulation systems, peripheral neurostimulation platforms and associated implantable pulse generators, leads and programming systems.

Growth is being supported by Parkinson’s disease, essential tremor, epilepsy, chronic neurological pain and other medically refractory conditions. Deep brain stimulation is particularly attractive because adaptive algorithms, directional stimulation, rechargeability, sensing capability and improved MRI compatibility are creating a technology replacement cycle.

The economics of the segment also favor recurring revenue. Initial implantation is followed by programming, replacement, accessories, remote follow-up and long-term patient management. Manufacturers therefore compete on complete therapy ecosystems rather than the implant alone.

Interventional Neurology and Neurovascular Devices

Interventional neurology is one of the most procedure-intensive categories. Products include aspiration catheters, stent retrievers, embolic coils, flow diverters, intracranial stents, microcatheters, guidewires, guide catheters, balloon catheters, embolic agents, access systems and specialized devices used for aneurysm and arteriovenous-malformation treatment.

Acute ischemic stroke represents the principal volume opportunity. With more than 795,000 strokes occurring annually and ischemic stroke comprising the large majority, hospitals are investing in comprehensive stroke infrastructure and faster endovascular workflows.

Aneurysm management is a second attractive opportunity. Minimally invasive embolization and flow-diversion approaches continue to gain clinical relevance, particularly for anatomically challenging cases. Product differentiation depends heavily on navigability, sizing flexibility, delivery stability and physician confidence.

Neurosurgery and CSF Management Devices

This category includes surgical instruments, ultrasonic aspirators, cranial fixation systems, neuroendoscopy products, stereotactic systems, external ventricular drains, hydrocephalus shunts, valves, intracranial pressure-management products, surgical access systems and selected brain-tumor technologies.

Demand is relatively durable because many applications are clinically necessary and cannot be deferred indefinitely. Hydrocephalus management creates recurring requirements for ventricular shunts, programmable valves and drainage products, while brain tumor and cranial surgery support demand for advanced instruments, visualization, navigation and tissue-management systems.

The category is increasingly influenced by minimally invasive access and image guidance. Hospitals are willing to invest in technologies that enable smaller surgical corridors, more precise lesion targeting and reduced operating-room time.

Neurodiagnostic and Monitoring Devices

Neurodiagnostic devices include EEG systems, ambulatory EEG, EMG and evoked-potential equipment, intraoperative neurophysiological monitoring technology, intracranial EEG, cerebral-function monitoring, seizure-detection technology and related software.

This segment benefits from the large epilepsy population as well as demand from intensive-care units, sleep laboratories, neurosurgery programs and outpatient neurology practices. Portable and ambulatory systems are particularly attractive because they allow data collection outside expensive inpatient environments.

AI-supported signal analysis represents an important growth layer. The core value proposition is not simply higher diagnostic accuracy; it is the ability to prioritize clinically significant events, reduce manual review burden and allow scarce neurophysiology specialists to manage larger patient volumes.

Focused Ultrasound, Navigation and Emerging Neurotechnology

The final product subsegment includes MR-guided focused ultrasound, neurosurgical navigation, robotic stereotactic platforms, advanced brain-computer interface systems and emerging minimally invasive neurological platforms.

Focused ultrasound has established a commercially relevant position in movement-disorder treatment. Navigation and robotic systems are increasingly embedded in DBS implantation, epilepsy surgery, biopsy and cranial procedures. Brain-computer interfaces remain an early-stage revenue opportunity but represent an important strategic innovation area for paralysis, communication restoration and direct neural control.

By Application

Stroke and Neurovascular Disorders

Stroke and related cerebrovascular conditions represent one of the largest application segments. The addressable device portfolio includes thrombectomy systems, aspiration catheters, stent retrievers, microcatheters, intracranial stents, coils, flow diverters and embolization products.

Because neurological damage progresses rapidly after vessel occlusion, hospitals value technologies that simplify device preparation, improve vessel access and increase the probability of successful reperfusion. Comprehensive stroke centers therefore represent especially important customers.

Parkinson’s Disease and Movement Disorders

Parkinson’s disease, essential tremor, dystonia and related movement disorders support demand for DBS, focused ultrasound, surgical navigation and functional neurosurgery products.

The application is entering a stronger growth phase because advanced treatment is becoming more personalized. Adaptive stimulation, smaller rechargeable implants, directional leads and incisionless focused ultrasound expand the available treatment architecture beyond conventional DBS.

Epilepsy and Seizure Disorders

The epilepsy segment includes diagnostic EEG, ambulatory monitoring, intracranial monitoring, responsive neurostimulation, vagus nerve stimulation, DBS and epilepsy-surgery technologies.

The combination of approximately 3 million adults with active epilepsy and persistent unmet need among drug-resistant patients provides a durable demand base. The largest future opportunity may emerge from integrating chronic electrophysiological data with AI-assisted clinical decision support.

Hydrocephalus, TBI and Neurocritical Care

Hydrocephalus, traumatic brain injury, intracranial hemorrhage and other neurocritical conditions require shunts, drainage systems, intracranial pressure monitors, surgical access technologies and multimodal monitoring.

More than 68,000 TBI-related deaths occurred in the United States in 2023, demonstrating the clinical severity of this category. Device purchasing decisions are heavily influenced by reliability, infection-control considerations, ease of bedside management and interoperability with ICU infrastructure.

Brain Tumors and Complex Neurosurgery

Brain tumor resection, biopsy, epilepsy surgery and complex cranial procedures support demand for surgical instruments, navigation platforms, stereotactic systems, ultrasonic tissue aspiration, intraoperative monitoring and robotic assistance.

Premium technology adoption is strongest at academic and tertiary neuroscience centers where higher case complexity can justify advanced capital investment.

By Technology Type

Implantable Neurological Devices

Implantable systems include DBS, responsive neurostimulation, vagus nerve stimulation, spinal cord stimulation, CSF shunts and selected implantable sensors. This technology class generates high revenue per treated patient and often creates long-term manufacturer relationships.

Future growth will be driven by rechargeable systems, closed-loop stimulation, brain sensing, smaller implants and remote programming.

Catheter-Based Neurointerventional Technology

Catheter-based devices include thrombectomy systems, aspiration catheters, embolization systems, flow diverters, intracranial stents, balloons, microcatheters and supporting access products.

This is one of the strongest procedure-volume technologies because products are generally consumed during each intervention. Increasing stroke thrombectomy and aneurysm-treatment volumes therefore translate directly into recurring device demand.

External and Non-Invasive Technology

External neurological technology includes EEG, EMG, transcranial magnetic stimulation, external stimulation systems, wearable neurological monitoring and focused ultrasound systems.

This segment benefits from movement toward outpatient diagnosis and treatment. Technologies capable of performing sophisticated neurological assessment without hospitalization can gain strong economic relevance.

Imaging-Guided, Robotic and Software-Enabled Technology

This category includes surgical navigation, stereotactic robotics, image-fusion systems, electrophysiological planning, AI-supported EEG analysis and software controlling intelligent stimulation.

Software is becoming increasingly important even when it does not independently represent the majority of device revenue. It can create switching costs, strengthen physician loyalty and improve the value of an installed hardware platform.

By End User

Hospitals and Integrated Health Systems

Hospitals account for the dominant share of U.S. neurology device spending because acute stroke intervention, neurosurgery, DBS implantation, neurocritical care and complex epilepsy procedures remain concentrated in hospital environments.

Large integrated systems increasingly negotiate enterprise contracts and standardize technology across multiple facilities. Manufacturers therefore require both physician advocacy and system-level economic evidence.

Academic Medical Centers and Neuroscience Institutes

Academic centers are strategically important early adopters. New neurovascular devices, adaptive stimulation, focused ultrasound, epilepsy implants and robotic neurosurgery frequently gain initial credibility through institutions conducting clinical studies and advanced procedures.

These centers also train physicians who subsequently influence technology adoption in community markets.

Ambulatory Surgery Centers and Outpatient Neurology Facilities

Selected neurological procedures are gradually migrating toward lower-cost settings when patient acuity permits. Ambulatory centers can support pain-related neurostimulation procedures, generator replacements and selected diagnostic services.

Products successful in this environment must combine clinical performance with simplified workflows and lower operating complexity.

Diagnostic Laboratories, Epilepsy Centers and Physician Practices

EEG, EMG, ambulatory monitoring and neurological assessment technologies are increasingly used outside major hospitals. Cloud connectivity and remote interpretation allow specialist practices to expand diagnostic capacity without duplicating hospital infrastructure.

Home and Remote Neurological Monitoring

Home neurological monitoring remains a smaller revenue category but has substantial growth potential. Ambulatory EEG, seizure-monitoring tools, wearable sensors and connected stimulation platforms can shift selected follow-up away from the hospital while generating longitudinal patient data.

Regional Insights: Where the Market is Growing Fastest

The U.S. Neurology Devices Market is geographically segmented into the South, West, Northeast and Midwest. Regional performance reflects population scale, stroke burden, age profile, academic neuroscience density, comprehensive stroke-center availability, health-system investment, specialist access and adoption of high-value neurological technologies.

The South is estimated to represent the largest regional market at approximately USD 1.60 billion in 2025, while the West is expected to record the fastest CAGR through 2035. The Northeast remains particularly important for high-acuity neurological innovation, while the Midwest provides a large and stable base of stroke, neurosurgical and neuromodulation procedures.

South

The South represents approximately USD 1.60 billion in 2025 and could approach USD 3.82 billion by 2035, representing growth of roughly 9.1% annually. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Tennessee, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma and West Virginia.

Texas is one of the most strategically important state markets. Houston, Dallas-Fort Worth, Austin and San Antonio contain large tertiary health systems, trauma programs and neuroscience institutes. The state’s population scale supports demand for thrombectomy, aneurysm treatment, epilepsy monitoring, neurosurgery and movement-disorder therapies.

Florida is equally significant because its large older population creates substantial demand for stroke care, Parkinson’s disease management, neurodiagnostics and neuromodulation. Large hospital networks across Miami, Tampa, Orlando, Jacksonville and South Florida provide a strong commercial base for neurological technology.

North Carolina has an influential academic and research ecosystem and strong referral centers. Georgia and Tennessee combine large metropolitan health systems with regional neuroscience programs, while Virginia and Maryland benefit from sophisticated hospital networks and proximity to federal biomedical research infrastructure.

Alabama, Mississippi, Louisiana, Kentucky, Arkansas, West Virginia and Oklahoma have substantial stroke and chronic neurological disease burdens but more uneven access to tertiary neurological care. These states create a different type of opportunity: scalable regional stroke networks, tele-neurology-supported diagnostics, portable EEG, efficient referral systems and technology that can extend specialist expertise beyond large metropolitan areas.

The South should remain the largest market through 2035 because population growth, aging demographics, stroke prevalence and continuing hospital expansion reinforce device utilization. Texas and Florida will remain the principal revenue centers, while North Carolina, Georgia, Tennessee and Virginia are expected to deliver strong incremental growth.

West

The West represents approximately USD 1.15 billion in 2025 and is projected to approach USD 2.93 billion by 2035, generating the fastest regional CAGR of approximately 9.8%. States include California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii.

California is the dominant Western state and one of the most important neurological-device markets nationally. Its large population, academic medical centers, biotechnology ecosystem, venture-capital base and concentration of neurotechnology companies create favorable conditions for early adoption.

California is particularly important for neurovascular innovation, stereotactic neurosurgery, epilepsy technology, AI-enabled neurological data analysis and emerging brain-computer interfaces. Major academic centers also participate in clinical studies that can influence adoption nationally.

Arizona and Nevada represent attractive growth markets because of migration and older demographics. Demand for stroke intervention, movement-disorder treatment and neurological surgery is increasing as hospital systems expand in Phoenix, Tucson, Las Vegas and surrounding metropolitan areas.

Colorado, Utah, Washington and Oregon combine sophisticated integrated health systems with strong adoption of digital care and advanced procedural technologies. These markets are attractive for software-connected neurodiagnostics and next-generation neuromodulation.

Geographic distance is a meaningful issue in Alaska, Montana, Idaho, Wyoming and parts of New Mexico. Technologies supporting remote diagnostics, regional stroke triage and efficient transfer to comprehensive centers have particular value in these states.

The West’s growth advantage comes from a combination of population growth and technology adoption. The region is expected to disproportionately benefit as neurology devices become more software-driven, connected, robotic and minimally invasive.

Northeast

The Northeast represents approximately USD 1.21 billion in 2025 and could reach USD 2.72 billion by 2035, corresponding to growth of approximately 8.4% annually. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, Vermont, New Hampshire and Delaware.

New York is the largest Northeast state market. New York City and major upstate health systems support complex neurosurgery, stroke intervention, epilepsy programs, neurocritical care and advanced movement-disorder treatment.

Massachusetts has an outsized influence relative to its population. Boston’s academic medical ecosystem makes the state important for clinical investigation, neurosurgical innovation, neurotechnology development and early adoption of premium technologies.

Pennsylvania and New Jersey provide large procedure pools across stroke, neurological surgery, epilepsy monitoring and neuromodulation. Pennsylvania has multiple major academic and regional referral centers, while New Jersey benefits from high population density and proximity to New York and Philadelphia medical markets.

Connecticut and Rhode Island are smaller but sophisticated markets. Maine, Vermont and New Hampshire have more distributed populations, making regional referral and remote neurological monitoring important components of market access.

The Northeast’s growth rate is expected to trail the West and South because its population growth is slower and its hospital market is already mature. Nevertheless, the region will remain exceptionally valuable because of procedure complexity, academic influence, specialist density and willingness to evaluate high-value neurological technology.

Midwest

The Midwest accounts for approximately USD 0.96 billion in 2025 and is projected to reach roughly USD 2.10 billion by 2035, representing growth of approximately 8.1% annually. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota and South Dakota.

Illinois is the region’s largest commercial center, driven primarily by Chicago’s major academic and community health systems. Stroke intervention, neurosurgery, epilepsy treatment and neurodiagnostics create a broad device market.

Ohio has a particularly strong neurological and cardiovascular hospital infrastructure, making it important for stroke and neurocritical care. Michigan also represents a sizeable market for neurovascular, neurosurgical and movement-disorder technology.

Minnesota occupies a unique position because of its medical-device ecosystem and concentration of neuromodulation expertise. The state is strategically important to manufacturers beyond its direct patient-market size because several major medtech organizations have deep operational histories there.

Indiana, Wisconsin and Missouri provide stable procedure volumes across regional hospital systems. Iowa, Kansas, Nebraska and the Dakotas are smaller markets where hub-and-spoke stroke systems, portable diagnostics and tele-neurology integration can improve access.

The Midwest is likely to expand more slowly than the South and West but should remain commercially dependable. Successful manufacturers in the region typically compete through clinical education, supply reliability, integrated health-system contracting and strong physician relationships.

Key Market Players

The U.S. Neurology Devices Competitive Landscape is moderately consolidated in major categories but highly fragmented across specialized neurotechnology niches. Large, diversified medtech companies control important positions in neurostimulation, neurovascular intervention and neurosurgery, while specialist companies compete in epilepsy, EEG, focused ultrasound, thrombectomy, intracranial access and advanced navigation.

Some of the key players operating in the U.S. Neurology Devices industry include:

Medtronic
Stryker Corporation
Abbott Laboratories
Boston Scientific Corporation
Johnson & Johnson MedTech / Cerenovus
Penumbra
Terumo Neuro / MicroVention
Integra LifeSciences
LivaNova
NeuroPace
Natus Medical
Nihon Kohden America
Cadwell Industries
Brainlab
Elekta
INSIGHTEC
ClearPoint Neuro
B. Braun / Aesculap
Zimmer Biomet
Imperative Care
Rapid Medical
Balt USA
Cerus Endovascular
NeuroOne Medical Technologies
Synchron

Medtronic, Abbott and Boston Scientific hold powerful positions in implantable neuromodulation and DBS. Their competitive advantages include established physician relationships, programming systems, implanted-device portfolios, clinical evidence and long-term service infrastructure.

Stryker, Johnson & Johnson MedTech, Penumbra and Terumo Neuro are particularly influential in neurovascular intervention. Competition is centered on thrombectomy, aspiration, aneurysm treatment, embolization, access systems and the ability to provide broad neurointerventional portfolios.

Integra LifeSciences and B. Braun/Aesculap participate across neurosurgical instrumentation, cranial procedures and related technologies. Brainlab, Elekta, ClearPoint Neuro and other specialized companies add value through image guidance, stereotactic planning, navigation and procedural workflow.

NeuroPace has established a differentiated position in responsive neurostimulation for epilepsy, while LivaNova participates through vagus nerve stimulation. Natus, Nihon Kohden and Cadwell are important participants in neurological diagnostics and neurophysiology.

INSIGHTEC has created an important commercial category around MR-guided focused ultrasound, while emerging neurotechnology companies such as Synchron represent the next frontier of brain-computer interfaces.

Competitive advantage through 2035 will depend increasingly on clinical evidence, software capability, physician training, regulatory execution, product reliability, reimbursement support, procedural efficiency and integration with neurological data.

Recent Developments

Recent developments demonstrate that the U.S. Neurology Devices Market is entering a more intelligent and personalized technology cycle.

In February 2025, FDA approval of an adaptive deep brain stimulation programming capability represented an important step toward closed-loop treatment of Parkinson’s disease. Rather than relying exclusively on fixed stimulation settings, adaptive systems can use brain signals to alter therapy according to neurological activity. The development could influence future DBS procurement by making sensing capability and software intelligence increasingly important competitive criteria.

Rechargeable DBS technology is also advancing. Newer implantable generators are being designed around smaller form factors, improved charging characteristics, remote programming capability and longer treatment lifecycles. These improvements address important patient concerns surrounding repeated generator replacement and chronic device management.

Focused ultrasound gained further momentum in 2025 with expansion of U.S. indications for treatment of advanced Parkinson’s disease. This strengthens the commercial position of incisionless functional neurosurgery and gives neuroscience centers another therapeutic platform alongside implanted DBS.

Epilepsy technology is entering an AI-enabled phase. In 2026, NeuroPace received FDA approval for an AI-driven feature designed to help clinicians interpret chronic electrocorticography information generated by responsive neurostimulation. This is strategically important because it demonstrates how manufacturers can convert implanted-device data into clinical workflow value.

The responsive neurostimulation opportunity may also expand into additional epilepsy populations. Regulatory submissions seeking broader indications demonstrate continued investment in closed-loop brain stimulation beyond traditional focal epilepsy populations.

Neurovascular innovation continues across aspiration thrombectomy, large-bore catheter systems, access technology, stent-retriever design, flow diversion and aneurysm treatment. The next commercial contest is increasingly centered on rapid lesion access and successful first-pass reperfusion rather than simply the availability of a thrombectomy platform.

Artificial intelligence is moving into neurological diagnostics as well. Automated EEG review, seizure detection, imaging triage, lesion characterization and procedural planning are becoming increasingly integrated with hardware platforms. The commercial value of AI will depend on whether it can measurably reduce physician workload or improve patient prioritization.

Brain-computer interfaces remain early stage but strategically important. Clinical programs are examining implanted interfaces that may allow people with severe paralysis to control external devices or communicate through neural signals. Revenue contribution remains modest, but the field could eventually establish a new high-value category within neurological devices.

The broader direction is clear: neurological devices are evolving from static hardware into connected therapeutic systems capable of sensing, interpreting and responding to neurological information.

Conclusion

The U.S. Neurology Devices Market Size & Share is positioned for strong expansion from approximately USD 4.92 billion in 2025 to USD 11.57 billion by 2035, representing an estimated 8.93% CAGR during 2026–2035.

Market growth will be supported by the combined burden of stroke, epilepsy, Parkinson’s disease, essential tremor, hydrocephalus, traumatic brain injury and other neurological conditions. However, disease prevalence alone will not determine commercial success. The strongest growth will occur where clinical need intersects with measurable workflow and economic advantages.

The most attractive opportunities include adaptive and sensing-enabled deep brain stimulation, responsive neurostimulation, mechanical thrombectomy, aspiration technology, next-generation aneurysm treatment, portable and AI-enabled EEG, MR-guided focused ultrasound, stereotactic navigation, neurosurgical robotics and connected neurocritical-care technology.

Neurostimulation should remain one of the largest premium-value categories, while interventional neurology will continue to benefit from high recurring procedural consumption. Neurodiagnostics will increasingly shift toward ambulatory, portable and AI-assisted workflows. Neurosurgical and CSF management products should provide durable baseline demand, while focused ultrasound, closed-loop stimulation and brain-computer interfaces create higher-growth innovation opportunities.

Geographically, the South is expected to remain the largest U.S. regional market, driven by Texas, Florida, North Carolina, Georgia, Tennessee and Virginia. The West is expected to record the fastest growth, led by California and supported by Arizona, Colorado, Washington, Utah and Nevada. The Northeast will remain a premium high-acuity market centered on New York, Massachusetts, Pennsylvania and New Jersey, while the Midwest will provide stable demand through Illinois, Ohio, Michigan, Minnesota and other major regional health systems.

Hospital procurement behavior will be critical. Neuroscience service lines require substantial specialist and capital resources, meaning hospitals cannot evaluate devices solely by purchase price. Technologies capable of reducing procedure time, improving first-pass stroke reperfusion, reducing hospital stay, limiting repeat surgery, expanding outpatient eligibility, improving specialist productivity or generating useful longitudinal data will have a stronger value proposition.

Competitive strategy is also becoming increasingly platform-oriented. Companies that combine implants with sensing, software, analytics, imaging, procedural tools, physician education and remote support will be better positioned than companies selling isolated hardware.

For manufacturers, investors, distributors and healthcare strategy teams evaluating the U.S. neurology devices industry, the central question is therefore not simply how quickly the market will expand. The more important issue is where neurological care is moving from conventional intervention toward intelligent, minimally invasive and data-driven treatment—and which device platforms can demonstrate enough clinical and economic value to become embedded within that next-generation workflow.

Between 2026 and 2035, companies capable of combining neurological precision with hospital-level economic value are expected to capture a disproportionate share of the U.S. Neurology Devices Market’s projected expansion.

TABLE OF CONTENT

1. U.S. Neurology Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Neurology Device Manufacturers
1.6.2. Component, Implant and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Health Systems
1.6.4. Academic Neuroscience Institutes and Specialty Neurology Centers
1.6.5. Ambulatory Surgery Centers and Outpatient Neurology Facilities
1.6.6. Neurodiagnostic Laboratories and Epilepsy Centers
1.6.7. Group Purchasing Organizations, Distributors and Specialty Suppliers
1.6.8. Payers, FDA, CMS and Clinical Decision-Makers
What this section provides: This section defines the U.S. neurology devices market boundary, study scope, methodology, assumptions, inclusion and exclusion criteria, and stakeholder ecosystem so clients understand how market size, segmentation, and forecasts are developed and validated.

2. U.S. Neurology Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.7.1. Adaptive and Closed-Loop Neurostimulation
2.7.2. Mechanical Thrombectomy and Neurovascular Intervention
2.7.3. Responsive Neurostimulation for Epilepsy
2.7.4. MR-Guided Focused Ultrasound
2.7.5. AI-Enabled Neurodiagnostics and EEG Analysis
2.7.6. Image-Guided and Robotic Neurosurgery
What this section provides: This section gives decision-makers a concise view of U.S. neurology device market size, historical performance, 2025 positioning, 2026–2035 growth trajectory, technology momentum, competitive intensity, and the highest-value commercial opportunity areas.

3. U.S. Neurology Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Burden of Stroke and Neurovascular Disorders
3.1.2. Increasing Prevalence of Parkinson’s Disease and Movement Disorders
3.1.3. Large U.S. Epilepsy and Drug-Resistant Epilepsy Patient Population
3.1.4. Expansion of Minimally Invasive Neurointerventional Procedures
3.1.5. Growing Adoption of Deep Brain Stimulation and Neuromodulation
3.1.6. Expansion of Comprehensive Stroke Centers and Neuroscience Programs
3.1.7. Growth in Ambulatory EEG and Remote Neurological Monitoring
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital and Implantable Device Costs
3.2.2. Reimbursement Complexity and Hospital Value Analysis Scrutiny
3.2.3. Neurosurgeon, Neurologist and Neurointerventionalist Workforce Constraints
3.2.4. Implant-Related Complications and Device Safety Risks
3.2.5. Long Clinical Evidence and Physician Training Requirements
3.3. Opportunities and Their Impact Analysis
3.3.1. Adaptive Deep Brain Stimulation
3.3.2. Responsive Neurostimulation and Closed-Loop Epilepsy Therapy
3.3.3. Next-Generation Stroke Thrombectomy Platforms
3.3.4. Flow Diversion and Advanced Aneurysm Treatment
3.3.5. MR-Guided Focused Ultrasound Expansion
3.3.6. AI-Assisted EEG and Neurodiagnostic Interpretation
3.3.7. Robotic and Image-Guided Neurosurgery
3.3.8. Brain-Computer Interfaces and Emerging Neurotechnology
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Neuroscience Service-Line Economics and Referral Capture Analysis
What this section provides: This section evaluates the disease, clinical, reimbursement, workforce, technological and hospital-economic forces shaping U.S. neurology device demand and helps clients quantify both market upside and commercialization risks.

4. U.S. Neurology Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization and Connected Neurology
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Coverage Landscape
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Neurological Public Health Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital Value Analysis Committee Decision Framework
4.13. Clinical Evidence, Real-World Evidence and Health-Economic Requirements
4.14. Cybersecurity and Connected Neurological Device Considerations
What this section provides: This section gives clients an integrated view of regulation, reimbursement, pricing, supply chain, digitalization, FDA requirements, technological adoption, hospital purchasing behavior and external forces affecting the U.S. neurology devices industry.

5. U.S. Neurology Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Neurostimulation and Neuromodulation Devices
5.1.2.1. Deep Brain Stimulation Systems
5.1.2.2. Responsive Neurostimulation Systems
5.1.2.3. Vagus Nerve Stimulation Systems
5.1.2.4. Spinal Cord and Peripheral Neurostimulation Systems
5.1.2.5. Implantable Pulse Generators, Leads and Programming Systems
5.1.3. Neurovascular and Interventional Neurology Devices
5.1.3.1. Stent Retrievers
5.1.3.2. Aspiration and Thrombectomy Catheters
5.1.3.3. Embolic Coils
5.1.3.4. Flow Diverters
5.1.3.5. Intracranial Stents
5.1.3.6. Microcatheters and Guide Catheters
5.1.3.7. Guidewires and Neurovascular Access Systems
5.1.3.8. Liquid Embolic and Aneurysm Treatment Systems
5.1.4. Neurosurgery and CSF Management Devices
5.1.4.1. Hydrocephalus Shunts and Programmable Valves
5.1.4.2. External Ventricular Drainage Systems
5.1.4.3. Intracranial Pressure Monitoring Devices
5.1.4.4. Neuroendoscopy Systems
5.1.4.5. Cranial Fixation and Surgical Access Systems
5.1.4.6. Ultrasonic Aspirators and Neurosurgical Instruments
5.1.5. Neurodiagnostic and Monitoring Devices
5.1.5.1. Electroencephalography Systems
5.1.5.2. Ambulatory and Portable EEG Devices
5.1.5.3. Electromyography and Evoked Potential Systems
5.1.5.4. Intracranial EEG and SEEG Systems
5.1.5.5. Intraoperative Neurophysiological Monitoring Systems
5.1.5.6. Cerebral and Neurocritical Monitoring Systems
5.1.6. Focused Ultrasound, Navigation and Emerging Neurotechnology
5.1.6.1. MR-Guided Focused Ultrasound Systems
5.1.6.2. Stereotactic Navigation Systems
5.1.6.3. Robotic Neurosurgical Platforms
5.1.6.4. Brain-Computer Interface Systems
5.1.6.5. Emerging Minimally Invasive Neurological Platforms
What this section provides: This section identifies the product categories generating the largest revenue contribution and highest growth potential, while separating recurring interventional consumables, implantables, diagnostic platforms, neurosurgical systems and emerging neurotechnology.

6. U.S. Neurology Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Stroke and Neurovascular Disorders
6.1.2.1. Acute Ischemic Stroke
6.1.2.2. Intracranial Aneurysm
6.1.2.3. Arteriovenous Malformations
6.1.2.4. Intracranial Stenosis and Other Cerebrovascular Disorders
6.1.3. Parkinson’s Disease and Movement Disorders
6.1.3.1. Parkinson’s Disease
6.1.3.2. Essential Tremor
6.1.3.3. Dystonia
6.1.3.4. Other Movement Disorders
6.1.4. Epilepsy and Seizure Disorders
6.1.4.1. Diagnostic Epilepsy Monitoring
6.1.4.2. Drug-Resistant Focal Epilepsy
6.1.4.3. Generalized Epilepsy
6.1.4.4. Surgical Epilepsy Evaluation and Treatment
6.1.5. Hydrocephalus, TBI and Neurocritical Care
6.1.5.1. Adult and Pediatric Hydrocephalus
6.1.5.2. Traumatic Brain Injury
6.1.5.3. Intracranial Hemorrhage
6.1.5.4. Neurocritical Care Monitoring
6.1.6. Brain Tumors and Complex Neurosurgery
6.1.6.1. Brain Tumor Resection
6.1.6.2. Stereotactic Biopsy
6.1.6.3. Functional Neurosurgery
6.1.6.4. Complex Cranial Procedures
What this section provides: This section assesses U.S. neurology device demand by major clinical indication and allows clients to identify applications with the strongest patient pool, procedure growth, unmet need, reimbursement relevance and technology adoption.

7. U.S. Neurology Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.3. Academic Medical Centers and Neuroscience Institutes
7.1.4. Ambulatory Surgery Centers and Outpatient Neurology Facilities
7.1.5. Diagnostic Laboratories, Epilepsy Centers and Physician Practices
7.1.6. Home and Remote Neurological Monitoring Providers
What this section provides: This section explains which U.S. care settings generate the largest neurology device expenditure and where future purchasing is shifting as diagnostics, monitoring and selected procedures migrate beyond traditional inpatient environments.

8. U.S. Neurology Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Implantable Neurological Devices
8.1.2.1. Open-Loop Implantable Systems
8.1.2.2. Closed-Loop and Adaptive Implantable Systems
8.1.2.3. Rechargeable Implantable Systems
8.1.2.4. Sensing-Enabled Neurological Implants
8.1.3. Catheter-Based Neurointerventional Technologies
8.1.3.1. Aspiration Technologies
8.1.3.2. Mechanical Thrombectomy Technologies
8.1.3.3. Embolization Technologies
8.1.3.4. Flow-Diversion Technologies
8.1.3.5. Neurovascular Access Technologies
8.1.4. External and Non-Invasive Technologies
8.1.4.1. EEG and Neurophysiology Systems
8.1.4.2. Wearable Neurological Monitoring
8.1.4.3. Transcranial Stimulation Technologies
8.1.4.4. Focused Ultrasound Technologies
8.1.5. Imaging-Guided and Robotic Technologies
8.1.5.1. Stereotactic Navigation
8.1.5.2. Image-Fusion Systems
8.1.5.3. Robotic Neurosurgical Platforms
8.1.5.4. Intraoperative Guidance Technologies
8.1.6. Software-Enabled and AI-Assisted Neurotechnology
8.1.6.1. AI-Assisted EEG Analysis
8.1.6.2. Neurological Image Analysis
8.1.6.3. Closed-Loop Stimulation Algorithms
8.1.6.4. Remote Programming and Monitoring Platforms
8.1.6.5. Digital Neurological Workflow Platforms
What this section provides: This section evaluates the technology architectures reshaping neurological care, including implantables, neurointerventional catheters, non-invasive systems, robotics, navigation and AI-enabled neurological platforms.

9. U.S. Neurology Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Distributor and Specialty Neurotechnology Supplier Sales
9.1.6. Ambulatory, Diagnostic and Physician-Practice Procurement
What this section provides: This section explains how neurology devices are purchased in the United States, including IDN standardization, capital-equipment approval, GPO influence, physician preference, specialty distribution and outpatient purchasing behavior.

10. U.S. Neurology Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Neurological Disease and Procedure Volume Analysis
10.1.4. Comprehensive Stroke Center and Neuroscience Infrastructure Analysis
10.1.5. Regional Reimbursement and Procurement Dynamics
10.1.6. Neurologist, Neurosurgeon and Neurointerventionalist Availability Analysis

10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Neurology Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Neurology Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Neurology Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Neurology Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level neurology device analysis, helping clients identify priority U.S. geographies, stroke and neuroscience procedure hubs, advanced neurotechnology adoption hotspots, health-system procurement centers and state-level commercial opportunities.

11. U.S. Neurology Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Medtronic
11.3.2. Stryker Corporation
11.3.3. Abbott Laboratories
11.3.4. Boston Scientific Corporation
11.3.5. Johnson & Johnson MedTech / Cerenovus
11.3.6. Penumbra
11.3.7. Terumo Neuro / MicroVention
11.3.8. Integra LifeSciences
11.3.9. LivaNova
11.3.10. NeuroPace
11.3.11. Natus Medical
11.3.12. Nihon Kohden America
11.3.13. Cadwell Industries
11.3.14. Brainlab
11.3.15. Elekta
11.3.16. INSIGHTEC
11.3.17. ClearPoint Neuro
11.3.18. B. Braun / Aesculap
11.3.19. Zimmer Biomet
11.3.20. Imperative Care
11.3.21. Rapid Medical
11.3.22. Balt USA
11.3.23. Cerus Endovascular
11.3.24. NeuroOne Medical Technologies
11.3.25. Synchron
Note: Each company profile will include company overview, neurology device portfolio, U.S. market strategy, financial positioning, clinical pipeline, FDA and regulatory developments, technology positioning, partnerships, acquisitions, product launches and recent strategic developments.
11.4. Product Portfolio Benchmarking
11.5. Competitive Benchmarking by Neurology Device Category
11.6. Mergers, Acquisitions, Partnerships and Strategic Alliances, 2021–2026
11.7. FDA Approval and Product Launch Benchmarking
What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, product-category exposure, innovation direction, FDA pipeline intelligence and strategic analysis of 25 major and emerging U.S. neurology device companies.

12. U.S. Neurology Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Adaptive and Closed-Loop Neurostimulation
12.2.2. Next-Generation Mechanical Thrombectomy and Neurovascular Platforms
12.2.3. AI-Assisted EEG and Neurological Diagnostics
12.2.4. MR-Guided Focused Ultrasound
12.2.5. Robotic and Image-Guided Neurosurgery
12.2.6. Brain-Computer Interfaces
12.2.7. Connected Neurological Monitoring and Digital Neurotechnology
12.3. Emerging Business Trends
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Adoption Curve, 2026–2035
12.7. Future Hospital Neuroscience Infrastructure Requirements
What this section provides: This section prepares clients for future market scenarios, disruptive neurological technologies, emerging investment themes, changing hospital infrastructure requirements and the technology categories most likely to reshape the competitive landscape through 2035.

13. U.S. Neurology Devices Market: Strategic Recommendations

13.1. Recommendations for Neurology Device Manufacturers
13.2. Recommendations for Hospitals and Health Systems
13.3. Recommendations for Academic Neuroscience Centers
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Neurotechnology Startups
13.7. Go-to-Market Strategy Considerations
13.8. Product Positioning and Portfolio Expansion Guidance
13.9. Hospital and IDN Contracting Strategy
13.10. Clinical Evidence and Physician Adoption Strategy
13.11. State-Level Commercial Prioritization Strategy
What this section provides: This section translates market intelligence into actionable commercial strategy for product development, U.S. market entry, clinical adoption, health-system contracting, portfolio expansion, investment prioritization and competitive differentiation.

14. U.S. Neurology Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Estimation and Model Limitation
What this section provides: This section clarifies the report’s research limitations, market-model boundaries, forecasting assumptions, third-party data considerations, legal conditions and appropriate use of the U.S. Neurology Devices Market analysis.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Neurology Devices Market: Market Definition and Scope
TABLE 3: U.S. Neurology Devices Market: Research Methodology Framework
TABLE 4: U.S. Neurology Devices Market: Key Assumptions
TABLE 5: U.S. Neurology Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Neurology Devices Market: Stakeholder Analysis
TABLE 7: U.S. Neurology Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Neurology Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Neurology Devices Market: Market Attractiveness Index
TABLE 10: U.S. Neurology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Neurology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Neurology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Neurology Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Neurology Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Neurology Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Neurology Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Neurology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Neurology Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Neurology Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Neurology Devices Market: PESTEL Analysis
TABLE 21: U.S. Neurology Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Neurology Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Neurology Devices Market: Value Chain Analysis
TABLE 24: U.S. Neurology Devices Market: Supply Chain Analysis
TABLE 25: U.S. Neurology Devices Market: Digitalization and Connected Neurology Impact
TABLE 26: U.S. Neurology Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Neurology Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Neurology Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Neurology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Neurology Devices Market: Government Initiatives and Neurological Public Health Programs
TABLE 31: U.S. Neurology Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Neurology Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 33: U.S. Neurology Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Neurology Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Neurology Devices Market: Neurostimulation and Neuromodulation Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Neurology Devices Market: Neurovascular and Interventional Neurology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Neurology Devices Market: Neurosurgery and CSF Management Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Neurology Devices Market: Neurodiagnostic and Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Neurology Devices Market: Focused Ultrasound, Navigation and Emerging Neurotechnology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Neurology Devices Market: Application Snapshot, 2025
TABLE 43: Segment Dashboard; Definition and Scope, by Application
TABLE 44: U.S. Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 45: U.S. Neurology Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 46: U.S. Neurology Devices Market: Stroke and Neurovascular Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Neurology Devices Market: Parkinson’s Disease and Movement Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Neurology Devices Market: Epilepsy and Seizure Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Neurology Devices Market: Hydrocephalus, TBI and Neurocritical Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Neurology Devices Market: Brain Tumors and Complex Neurosurgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Neurology Devices Market: End User Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by End User
TABLE 53: U.S. Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 54: U.S. Neurology Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 55: U.S. Neurology Devices Market: Hospitals and Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Neurology Devices Market: Academic Medical Centers and Neuroscience Institutes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Neurology Devices Market: Ambulatory Surgery Centers and Outpatient Neurology Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Neurology Devices Market: Diagnostic Laboratories, Epilepsy Centers and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Neurology Devices Market: Home and Remote Neurological Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Neurology Devices Market: Technology Type Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 62: U.S. Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 63: U.S. Neurology Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 64: U.S. Neurology Devices Market: Implantable Neurological Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Neurology Devices Market: Catheter-Based Neurointerventional Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Neurology Devices Market: External and Non-Invasive Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Neurology Devices Market: Imaging-Guided and Robotic Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Neurology Devices Market: Software-Enabled and AI-Assisted Neurotechnology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Neurology Devices Market: Procurement Channel Snapshot, 2025
TABLE 70: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 71: U.S. Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 72: U.S. Neurology Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 73: U.S. Neurology Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Neurology Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Neurology Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Neurology Devices Market: Distributor and Specialty Neurotechnology Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Neurology Devices Market: Ambulatory, Diagnostic and Physician-Practice Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Neurology Devices Market: Regional Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Region
TABLE 80: U.S. Neurology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 81: U.S. Neurology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 82: West Region U.S. Neurology Devices Market: Regional Overview and Trends
TABLE 83: West Region U.S. Neurology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 84: West Region U.S. Neurology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 90: California Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 91: California Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 92: California Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 93: California Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 94: California Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 95: Washington Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 96: Washington Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 97: Washington Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: Washington Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 99: Washington Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 100: Arizona Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 101: Arizona Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 102: Arizona Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: Arizona Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 104: Arizona Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: Colorado Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 106: Colorado Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: Colorado Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: Colorado Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 109: Colorado Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Oregon Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 111: Oregon Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 112: Oregon Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: Oregon Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 114: Oregon Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Utah Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Utah Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Utah Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Utah Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 119: Utah Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: Nevada Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 121: Nevada Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Nevada Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Nevada Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 124: Nevada Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: New Mexico Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 126: New Mexico Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: Idaho Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 131: Idaho Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: Idaho Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: Idaho Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: Idaho Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: Montana Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 136: Montana Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 137: Montana Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 138: Montana Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 139: Montana Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Wyoming Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 141: Wyoming Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Alaska Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 146: Alaska Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 147: Alaska Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 148: Alaska Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 149: Alaska Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Hawaii Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 151: Hawaii Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Northeast Region U.S. Neurology Devices Market: Regional Overview and Trends
TABLE 156: Northeast Region U.S. Neurology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 157: Northeast Region U.S. Neurology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 158: Northeast Region U.S. Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 159: Northeast Region U.S. Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: New York Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 164: New York Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: New York Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 166: New York Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 167: New York Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: Massachusetts Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 169: Massachusetts Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: New Jersey Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 174: New Jersey Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: Pennsylvania Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 179: Pennsylvania Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 183: Connecticut Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 184: Connecticut Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 188: Maine Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 189: Maine Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 190: Maine Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 191: Maine Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 192: Maine Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 193: Vermont Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 194: Vermont Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: Vermont Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: Vermont Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 197: Vermont Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 198: New Hampshire Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 199: New Hampshire Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 203: Rhode Island Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 204: Rhode Island Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 208: Delaware Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 209: Delaware Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 210: Delaware Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 211: Delaware Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 212: Delaware Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 213: South Region U.S. Neurology Devices Market: Regional Overview and Trends
TABLE 214: South Region U.S. Neurology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 215: South Region U.S. Neurology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 216: South Region U.S. Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 217: South Region U.S. Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: Texas Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 222: Texas Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 223: Texas Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 224: Texas Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 225: Texas Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 226: Florida Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 227: Florida Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 228: Florida Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 229: Florida Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 230: Florida Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 231: Georgia Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 232: Georgia Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 233: Georgia Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 234: Georgia Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 235: Georgia Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 236: North Carolina Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 237: North Carolina Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 241: Tennessee Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 242: Tennessee Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 246: South Carolina Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 247: South Carolina Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 251: Alabama Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 252: Alabama Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 253: Alabama Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 254: Alabama Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 255: Alabama Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 256: Mississippi Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 257: Mississippi Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 261: Louisiana Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 262: Louisiana Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 266: Arkansas Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 267: Arkansas Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 271: Kentucky Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 272: Kentucky Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 276: Oklahoma Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 277: Oklahoma Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 281: Virginia Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 282: Virginia Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 283: Virginia Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 284: Virginia Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 285: Virginia Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 286: Maryland Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 287: Maryland Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 288: Maryland Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 289: Maryland Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 290: Maryland Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 291: West Virginia Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 292: West Virginia Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 296: Midwest Region U.S. Neurology Devices Market: Regional Overview and Trends
TABLE 297: Midwest Region U.S. Neurology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 298: Midwest Region U.S. Neurology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 299: Midwest Region U.S. Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 300: Midwest Region U.S. Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 304: Illinois Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 305: Illinois Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 306: Illinois Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 307: Illinois Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 308: Illinois Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 309: Ohio Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 310: Ohio Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: Ohio Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: Ohio Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 313: Ohio Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 314: Michigan Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 315: Michigan Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 316: Michigan Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 317: Michigan Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 318: Michigan Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 319: Minnesota Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 320: Minnesota Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 324: Indiana Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 325: Indiana Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 326: Indiana Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 327: Indiana Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 328: Indiana Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 329: Wisconsin Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 330: Wisconsin Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 334: Missouri Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 335: Missouri Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 336: Missouri Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 337: Missouri Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 338: Missouri Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 339: Iowa Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 340: Iowa Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 341: Iowa Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 342: Iowa Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 343: Iowa Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 344: Kansas Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 345: Kansas Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 346: Kansas Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 347: Kansas Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 348: Kansas Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 349: Nebraska Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 350: Nebraska Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 354: North Dakota Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 355: North Dakota Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 359: South Dakota Neurology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 360: South Dakota Neurology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Neurology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Neurology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Neurology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 364: U.S. Neurology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 365: U.S. Neurology Devices Market: Key Company Market Share Analysis, 2025
TABLE 366: U.S. Neurology Devices Market: Company Positioning Matrix
TABLE 367: U.S. Neurology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 368: U.S. Neurology Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 369: Medtronic: Company Profile
TABLE 370: Stryker Corporation: Company Profile
TABLE 371: Abbott Laboratories: Company Profile
TABLE 372: Boston Scientific Corporation: Company Profile
TABLE 373: Johnson & Johnson MedTech / Cerenovus: Company Profile
TABLE 374: Penumbra: Company Profile
TABLE 375: Terumo Neuro / MicroVention: Company Profile
TABLE 376: Integra LifeSciences: Company Profile
TABLE 377: LivaNova: Company Profile
TABLE 378: NeuroPace: Company Profile
TABLE 379: Natus Medical: Company Profile
TABLE 380: Nihon Kohden America: Company Profile
TABLE 381: Cadwell Industries: Company Profile
TABLE 382: Brainlab: Company Profile
TABLE 383: Elekta: Company Profile
TABLE 384: INSIGHTEC: Company Profile
TABLE 385: ClearPoint Neuro: Company Profile
TABLE 386: B. Braun / Aesculap: Company Profile
TABLE 387: Zimmer Biomet: Company Profile
TABLE 388: Imperative Care: Company Profile
TABLE 389: Rapid Medical: Company Profile
TABLE 390: Balt USA: Company Profile
TABLE 391: Cerus Endovascular: Company Profile
TABLE 392: NeuroOne Medical Technologies: Company Profile
TABLE 393: Synchron: Company Profile
TABLE 394: U.S. Neurology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 395: U.S. Neurology Devices Market: Disruptive Technologies Impact Matrix
TABLE 396: U.S. Neurology Devices Market: Emerging Business Trends
TABLE 397: U.S. Neurology Devices Market: Business Opportunities for Startups and Existing Players
TABLE 398: U.S. Neurology Devices Market: Investment Prioritization Matrix
TABLE 399: U.S. Neurology Devices Market: Strategic Recommendations for Neurology Device Manufacturers
TABLE 400: U.S. Neurology Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 401: U.S. Neurology Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 402: U.S. Neurology Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 403: U.S. Neurology Devices Market: Strategic Recommendations for New Entrants and Neurotechnology Startups
TABLE 404: U.S. Neurology Devices Market: Go-to-Market Strategy Considerations
TABLE 405: U.S. Neurology Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 406: U.S. Neurology Devices Market: Scope Limitation
TABLE 407: U.S. Neurology Devices Market: Data Use Limitation
TABLE 408: U.S. Neurology Devices Market: Forecasting Limitation
TABLE 409: U.S. Neurology Devices Market: Legal Disclaimer
TABLE 410: U.S. Neurology Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Neurology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Neurology Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Neurology Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Neurology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Neurostimulation and Neuromodulation Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Neurovascular and Interventional Neurology Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Neurosurgery and CSF Management Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Neurodiagnostic and Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Focused Ultrasound, Navigation and Emerging Neurotechnology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Stroke and Neurovascular Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Parkinson’s Disease and Movement Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Epilepsy and Seizure Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Hydrocephalus, TBI and Neurocritical Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Brain Tumors and Complex Neurosurgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 30: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Hospitals and Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Academic Medical Centers and Neuroscience Institutes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Ambulatory Surgery Centers and Outpatient Neurology Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Diagnostic Laboratories, Epilepsy Centers and Physician Practices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Home and Remote Neurological Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 37: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Implantable Neurological Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Catheter-Based Neurointerventional Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: External and Non-Invasive Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Imaging-Guided and Robotic Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Software-Enabled and AI-Assisted Neurotechnology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Distributor and Specialty Neurotechnology Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Ambulatory, Diagnostic and Physician-Practice Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: West Region U.S. Neurology Devices Market Share and Leading Players, 2025
FIGURE 53: West Region Market Share Analysis by State, 2025
FIGURE 54: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: California Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Washington Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Arizona Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Colorado Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Oregon Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Utah Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Nevada Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: New Mexico Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Idaho Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Montana Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Wyoming Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Alaska Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Hawaii Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Northeast Region U.S. Neurology Devices Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Maine Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Vermont Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Hampshire Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Rhode Island Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Delaware Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: South Region U.S. Neurology Devices Market Share and Leading Players, 2025
FIGURE 82: South Region Market Share Analysis by State, 2025
FIGURE 83: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Texas Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Florida Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Georgia Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: North Carolina Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Tennessee Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: South Carolina Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Alabama Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Mississippi Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Louisiana Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Arkansas Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Kentucky Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Oklahoma Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Virginia Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Maryland Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: West Virginia Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Midwest Region U.S. Neurology Devices Market Share and Leading Players, 2025
FIGURE 100: Midwest Region Market Share Analysis by State, 2025
FIGURE 101: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Illinois Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Ohio Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Michigan Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Minnesota Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Indiana Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Wisconsin Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Missouri Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Iowa Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Kansas Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Nebraska Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: North Dakota Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: South Dakota Neurology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 115: Company Positioning Matrix
FIGURE 116: Key Player Product Portfolio Benchmarking
FIGURE 117: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 118: Neurology Device Innovation Roadmap
FIGURE 119: Adaptive and Closed-Loop Neurostimulation Adoption Roadmap
FIGURE 120: Neurovascular and Mechanical Thrombectomy Technology Opportunity Map
FIGURE 121: AI-Enabled Neurodiagnostics and Remote Neurological Monitoring Growth Roadmap
FIGURE 122: Future Market Scenario Analysis, 2026–2035
FIGURE 123: Disruptive Technologies Impact Matrix
FIGURE 124: Emerging Business Trends Matrix
FIGURE 125: Investment Prioritization Matrix
FIGURE 126: Strategic Growth Roadmap for U.S. Neurology Device Companies
FIGURE 127: Go-to-Market Strategy Framework
FIGURE 128: Product Positioning and Portfolio Expansion Framework
FIGURE 129: Report Scope and Disclaimer Framework